Article
Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Aug 1999
Bosio E, Beilharz M W, Watson M W, Lawson C M
Abstract excerpt
Oral administration of type I interferons (IFNs; murine IFN-alpha and IFN-beta) reduces early replication of murine cytomegalovirus (MCMV) in both the spleen and liver of MCMV-infected BALB/c mice. Examination of a range of doses of IFN (1 to 1000 IU) showed that 10 IU administered daily for 1 week prior to virus infection was optimal for inhibition of MCMV replication. Furthermore, low-dose orally administered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
